Shock lung and Disseminated intravascular coagulation - from FDA reports

Summary

Disseminated intravascular coagulation is found among people with Shock lung, especially for people who are male, 2-9 old, take medication Decadron and have Gastrointestinal haemorrhage. This review analyzes which people have Disseminated intravascular coagulation with Shock lung. It is created by eHealthMe based on reports of 8 people who have Shock lung from FDA, and is updated regularly.

What to expect?

If you have Shock lung and Disseminated intravascular coagulation, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who have Shock lung and Disseminated intravascular coagulation

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Apr, 23, 2017

8 people who have Shock Lung and Disseminated Intravascular Coagulation are studied.


Number of reports submitted per year:

Would you have Disseminated intravascular coagulation when you have Shock lung?

Gender of people who have Shock Lung and experience Disseminated Intravascular Coagulation *:

  • female: 42.86 %
  • male: 57.14 %

Age of people who have Shock Lung and experience Disseminated Intravascular Coagulation *:

  • 0-1: 42.86 %
  • 2-9: 42.86 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 14.29 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top co-existing conditions for these people *:

  • Gastrointestinal Haemorrhage (3 people, 37.50%)
  • Myelodysplastic Syndrome (1 person, 12.50%)
  • Itching (1 person, 12.50%)
  • Gastric Ulcer (1 person, 12.50%)
  • Enlarged Prostate (1 person, 12.50%)

Most common drugs for these people *:

  • Solu-Medrol (3 people, 37.50%)
  • Prednisolone (3 people, 37.50%)
  • Pepcid (3 people, 37.50%)
  • Decadron (3 people, 37.50%)
  • Zosyn (1 person, 12.50%)

Top symptoms for these people *:

  • Multi-Organ Failure (6 people, 75.00%)
  • Pneumonia (5 people, 62.50%)
  • Chickenpox (3 people, 37.50%)
  • Blood Bilirubin Increased (3 people, 37.50%)
  • Abdominal Tenderness (3 people, 37.50%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Disseminated intravascular coagulation and Shock lung?


Shock Lung

Shock lung (a condition in which the lungs suddenly become damaged) (latest reports from 15,031 Shock lung patients)

Disseminated Intravascular Coagulation

Disseminated intravascular coagulation (systemic activation of blood coagulation) has been reported by people with rheumatoid arthritis, preventive health care, high blood pressure, pain, atrial fibrillation/flutter (latest reports from 17,268 Disseminated intravascular coagulation patients).

Browse all symptoms of Shock lung

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Disseminated intravascular coagulation

Disseminated intravascular coagulation

Other conditions that could case Disseminated intravascular coagulation

Disseminated intravascular coagulation

Related studies

Can you answer these questions?

More questions for: Shock lung, Disseminated intravascular coagulation

You may be interested in these reviews

More reviews for: Shock lung, Disseminated intravascular coagulation